246 related articles for article (PubMed ID: 3283548)
1. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
Collins R; Scrimgeour A; Yusuf S; Peto R
N Engl J Med; 1988 May; 318(18):1162-73. PubMed ID: 3283548
[No Abstract] [Full Text] [Related]
2. Editorial: Low-dose heparin prophylaxis for postoperative venous thromboembolism.
Sherry S
N Engl J Med; 1975 Aug; 293(6):300-2. PubMed ID: 1138184
[No Abstract] [Full Text] [Related]
3. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.
Lancet; 1975 Jul; 2(7924):45-51. PubMed ID: 49649
[TBL] [Abstract][Full Text] [Related]
4. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.
White RH; Romano PS; Zhou H; Rodrigo J; Bargar W
Arch Intern Med; 1998 Jul; 158(14):1525-31. PubMed ID: 9679793
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.
Kakkar VV; Cohen AT; Edmonson RA; Phillips MJ; Cooper DJ; Das SK; Maher KT; Sanderson RM; Ward VP; Kakkar S
Lancet; 1993 Jan; 341(8840):259-65. PubMed ID: 8093915
[TBL] [Abstract][Full Text] [Related]
6. To Compare the Effectiveness of Low-Molecular-Weight Heparin and Unfractionated Heparin in Reducing Lower Limb Girth in Deep Vein Thrombosis.
Ullalkar N; M V; Pn S; Vaibhavi D; Ca S
Cureus; 2024 May; 16(5):e59449. PubMed ID: 38827007
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.
Kouvela M; Livanou ME; Stefanou DT; Vathiotis IA; Sarropoulou F; Grammoustianou M; Dimakakos E; Syrigos N
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611118
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
Douaisi M; Paskaleva EE; Fu L; Grover N; McManaman CL; Varghese S; Brodfuehrer PR; Gibson JM; de Joode I; Xia K; Brier MI; Simmons TJ; Datta P; Zhang F; Onishi A; Hirakane M; Mori D; Linhardt RJ; Dordick JS
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315586121. PubMed ID: 38498726
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism.
Dicks AB; Moussallem E; Stanbro M; Walls J; Gandhi S; Gray BH
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256496
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Sequential Compression Versus Ankle-Calf Movement to Increase Femoral Venous Velocity.
Kumar S; Azadi N; Emerson D; Santoso J
Cureus; 2023 Oct; 15(10):e48070. PubMed ID: 37927740
[TBL] [Abstract][Full Text] [Related]
11. Independent risk factors for an increased incidence of thromboembolism after lung transplantation.
Moneke I; Ogutur ED; Kalbhenn J; Hettich I; Passlick B; Jungraithmayr W; Senbaklavaci O
J Thromb Thrombolysis; 2023 Feb; 55(2):252-262. PubMed ID: 36495365
[TBL] [Abstract][Full Text] [Related]
12. The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors.
Mei R; Wang G; Chen R; Wang H
World J Surg Oncol; 2022 Sep; 20(1):245. PubMed ID: 36058927
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Deep Venous Thrombosis and Sickle Cell Disease in Patients Undergoing Spinal Surgery in South Gujarat, India: A Prospective Observational Study.
Menon HJ; Khanna AP; Patel YB
Malays Orthop J; 2022 Jul; 16(2):63-69. PubMed ID: 35992978
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis - A Retrospective Study.
Ambra N; Mohammad OH; Naushad VA; Purayil NK; Mohamedali MG; Elzouki AN; Khalid MK; Illahi MN; Palol A; Barman M; Sharif M; Chalihadan S; Punnorath A; Mostafa A; Al Hariri B; Khidir TGM; Varikkodan I
Vasc Health Risk Manag; 2022; 18():575-587. PubMed ID: 35912018
[TBL] [Abstract][Full Text] [Related]
15. Saudi plastic surgeons' venous thromboembolism prophylaxis practices in aesthetic surgery: A national study.
Arab K; Qasim SS; Mortada H; Al Qurashi AA; AlSahli AM; Qedair JT; Alghamdi H; Kattan A
JPRAS Open; 2022 Sep; 33():114-118. PubMed ID: 35845473
[No Abstract] [Full Text] [Related]
16. Are sequential compression devices routinely necessary following enhanced recovery after thoracic surgery?
Abdul SA; Anstee C; Villeneuve PJ; Gilbert S; Seely AJE; Sundaresan S; Maziak DE
Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35713491
[TBL] [Abstract][Full Text] [Related]
17. Electronic health record risk-stratification tool reduces venous thromboembolism events in surgical patients.
Rastogi R; Lattimore CM; Mehaffey JH; Turrentine FE; Maitland HS; Zaydfudim VM
Surg Open Sci; 2022 Jul; 9():34-40. PubMed ID: 35620709
[TBL] [Abstract][Full Text] [Related]
18. Perioperative consultative hematology: can you clear my patient for a procedure?
Burnett AE; Ragheb B; Kaatz S
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):521-528. PubMed ID: 34889442
[TBL] [Abstract][Full Text] [Related]
19. How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?
Klemen ND; Feingold PL; Hashimoto B
J Clin Oncol; 2022 Feb; 40(4):320-323. PubMed ID: 34871037
[No Abstract] [Full Text] [Related]
20. Analysis of Adherence to Thromboprophylaxis and Incidence of Venous Thromboembolism After Lower Limb Orthopaedic Surgery.
Benjamin MW; Koomson A; Ismaiel H
Cureus; 2021 Nov; 13(11):e19746. PubMed ID: 34812337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
